Not so bad: Nicotine restores brain function in schizophrenic patients | health and fitness | Hindustan Times
Today in New Delhi, India
Sep 21, 2017-Thursday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Not so bad: Nicotine restores brain function in schizophrenic patients

It is real good news for smokers who often look for obscure health benefits of nicotine to validate their addiction. Now you have science backing you. Turns out nicotine may help restore the brain activity of people suffering from schizophrenia, a psychiatric disorder that affects 51 million people worldwide.

health and fitness Updated: Jan 24, 2017 18:46 IST
Nicotine consumption isn't all that bad after all.
Nicotine consumption isn't all that bad after all.(Shutterstock)

It is real good news for smokers who often look for obscure health benefits of nicotine to validate their addiction. Now you have science backing you. Turns out nicotine may help restore the brain activity of people suffering from schizophrenia, a psychiatric disorder that affects 51 million people worldwide.

The findings of a new study showed that when mice with schizophrenic characteristics were given nicotine daily, their sluggish brain activity increased within two days and within a week it was normalised.

“Since the repeated administration of nicotine restores normal activity to the prefrontal cortex, it could pave the way for a possible therapeutic target for the treatment of schizophrenia,” said lead author Uwe Maskos from Integrative Neurobiology of Cholinergic Systems Unit or Institut Pasteur — a French non-profit private foundation.

The chemical combinations responsible for our emotions. (Shutterstock)

It has been observed that schizophrenic patients often use smoking as a form of self-medication to alleviate the deficit symptoms caused by their disorder or to combat the serious side effects of their treatment — lethargy, lack of motivation, etc.

Patients with schizophrenia — 80 to 90 per cent of whom are often heavy smokers — have impairments in the prefrontal cortex — the brain region associated with cognition, decision-making and working memory.

Recently, the genetic mutation CHRNA5, which encodes a nicotinic receptor subunit, was identified as being associated with the cognitive impairments in schizophrenic patients and with nicotine dependence.

In the new study, scientists introduced the human CHRNA5 gene into mice with the aim of reproducing the cerebral deficits that characterise schizophrenia, namely behavioural deficits in situations of social interaction and while performing sensorimotor tasks.

The results showed that mice with the CHRNA5 mutation had reduced activity in their prefrontal cortex.

The drop in activity measured in this model is similar to that observed in patients with psychiatric disorders such as schizophrenia and addiction, the researchers said.

The study was published online in the journal Nature Medicine.

Follow @htlifeandstyle for more